
Panion & BF Biotech Inc. — Investor Relations & Filings
Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 115年第1季財務報告書 — 202601_1760_AI1.pdf | 2026-05-13 | Chinese | |
| 公告本公司董事會通過115年第一季合併財務報告 | 2026-05-12 | Chinese | |
| 114年年報及股東會資料 — 2025_1760_20260525FE4.pdf | 2026-05-06 | Chinese | |
| 114年年報及股東會資料 — 2025_1760_20260525F04.pdf | 2026-05-06 | Chinese | |
| 114年年報及股東會資料 — 2026_1760_20260525F17.pdf | 2026-05-06 | Chinese | |
| 公告本公司115年第一季財務報告董事會預計召開日期 為115年5月12日 | 2026-05-06 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46262981 | 115年第1季財務報告書 — 202601_1760_AI1.pdf | 2026-05-13 | Chinese | ||
| 46231956 | 公告本公司董事會通過115年第一季合併財務報告 | 2026-05-12 | Chinese | ||
| 41672819 | 114年年報及股東會資料 — 2025_1760_20260525FE4.pdf | 2026-05-06 | Chinese | ||
| 41672755 | 114年年報及股東會資料 — 2025_1760_20260525F04.pdf | 2026-05-06 | Chinese | ||
| 41672487 | 114年年報及股東會資料 — 2026_1760_20260525F17.pdf | 2026-05-06 | Chinese | ||
| 41701989 | 公告本公司115年第一季財務報告董事會預計召開日期 為115年5月12日 | 2026-05-06 | Chinese | ||
| 37410318 | 本公司腎病新藥拿百磷獲得中國核准上市 | 2026-04-27 | Chinese | ||
| 36009646 | 115年年報及股東會資料 — 2026_1760_20260525FE2.pdf | 2026-04-24 | English | ||
| 36009583 | 115年年報及股東會資料 — 2026_1760_20260525F02.pdf | 2026-04-24 | Chinese | ||
| 36009218 | 115年年報及股東會資料 — 2026_1760_20260525F13.pdf | 2026-04-24 | Chinese | ||
| 36009196 | 115年年報及股東會資料 — 2026_1760_20260525FE1.pdf | 2026-04-24 | English | ||
| 36009170 | 115年年報及股東會資料 — 2026_1760_20260525F01.pdf | 2026-04-24 | Chinese | ||
| 35704949 | 115年04月僑外投資持股 | 2026-04-23 | Chinese | ||
| 33892917 | 115年3月背書保證與資金貸與 | 2026-04-09 | Chinese | ||
| 33892913 | 115年3月營業收入 | 2026-04-09 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
|
Ascendis Pharma A/S
Biopharmaceutical firm using its prodrug technology to trea…
|
ASND | DK | Manufacturing |
|
Ascentage Pharma Group International
Integrated biopharma developing novel small molecule therap…
|
6855 | HK | Manufacturing |
|
ASCENTAGE PHARMA GROUP INTERNATIONAL
A clinical-stage biopharma developing novel therapies for c…
|
AAPG | US | Manufacturing |
|
Ascletis Pharma Inc.
R&D driven biotech developing best-in-class therapeutics, p…
|
1672 | KY | Manufacturing |
Panion & BF Biotech Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51916/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51916 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51916 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51916 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51916}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Panion & BF Biotech Inc. (id: 51916)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.